Sangamo Therapeutics
SGMO
SGMO
184 hedge funds and large institutions have $744M invested in Sangamo Therapeutics in 2019 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 59 increasing their positions, 41 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
184
Holders Change
-1
Holders Change %
-0.54%
% of All Funds
4.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
59
Reduced
41
Closed
25
Calls
$14.9M
Puts
$12.1M
Net Calls
+$2.81M
Net Calls Change
-$7.64M
Top Buyers
| 1 |
MWNA
Marshall Wace North America
New York
|
$9.34M |
| 2 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
$5.63M |
| 3 |
Jennison Associates
New York
|
$4.67M |
| 4 |
Morgan Stanley
New York
|
$7.22M |
| 5 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
$62.4M |
